Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Genitourinary 1

Conditions

Brain Neoplasms 3Parkinson Disease 4, Autosomal Dominant Lewy Body 2Pain, Postoperative 2Pain 2Ovarian Neoplasms 2Neoplasms 2Warts 1Stroke 1Sepsis 1Schwannomatosis 1Prostatic Neoplasms 1Pleural Effusion 1Peritoneal Neoplasms 1Pancreatic Neoplasms 1Pancreatic Cyst 1Neuroinflammatory Diseases 1Neurilemmoma 1Multiple Myeloma 1Metastatic Non-Squamous Non-Small Cell Lung Cancer 1Lymphoma, Non-Hodgkin 1Lymphoma 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hypoxia 1Hyperthermia 1Hemorrhage 1Glycopyrrolate 1Fallopian Tube Neoplasms 1Esophageal Squamous Cell Carcinoma 1Erectile Dysfunction 1Colorectal Neoplasms 1

Interventions

Magnetic Resonance Spectroscopy 47enzalutamide 46apalutamide 36Specimen Handling 30Androgen Antagonists 30Abiraterone Acetate 29Radiosurgery 26Prednisone 25darolutamide 24Docetaxel 23Pluvicto 21abiraterone 19Radiotherapy 19Biopsy 17Leuprolide 15Surveys and Questionnaires 11Radiation 112-(3-(1-carboxy-5-((6-fluoropyridine-3-carbonyl)amino)pentyl)ureido)pentanedioic acid 11relugolix 10gallium 68 PSMA-11 10acetyl-2-naphthylalanyl-3-chlorophenylalanyl-1-oxohexadecyl-seryl-4-aminophenylalanyl(hydroorotyl)-4-aminophenylalanyl(carbamoyl)-leucyl-ILys-prolyl-alaninamide 10Standard of Care 10Nivolumab 10cabazitaxel 9Triptorelin Pamoate 9bicalutamide 8Carboplatin 8pembrolizumab 7olaparib 7niraparib 7

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Prostatic Neoplasms × Saline Solution × 90 days × Clear all
NCT07048314 2026-03-19

Stem Cells for Erectile Dysfunction Post RALP

The Methodist Hospital Research Institute

Phase 1/2 Not yet recruiting
40 enrolled
Genitourinary

Erectile Dysfunction, Prostatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡